Insider · CIK 0001237409

BARABE TIMOTHY C

Reports to the SEC for 7 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001237409

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-22	HTFLHeartflow, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,710 sh	$19.00	+$70.5K	188,231
2026-07-22	HTFLHeartflow, Inc. · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−3,710 sh	—	—	15,000
2026-07-17	HTFLHeartflow, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$19.00	+$95K	184,521
2026-07-17	HTFLHeartflow, Inc. · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	18,710
2026-06-16	HTFLHeartflow, Inc. · Stock OptionA Award	Director	AAward	+16.1K sh	$32.05	+$515K	16,075
2026-03-11	HTFLHeartflow, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+8,667 sh	$2.22	+$19.2K	179,521
2026-03-11	HTFLHeartflow, Inc. · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−8,667 sh	—	—	15,412
2026-02-17	HTFLHeartflow, Inc. · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−2,497 sh	—	—	0
2026-02-17	HTFLHeartflow, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,497 sh	$8.33	+$20.8K	170,854
2026-01-02	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,800 sh	—	—	7,800
2026-01-02	RNACCartesian Therapeutics, Inc.A Award	Director	AAward	+2,600 sh	—	—	56,966
2025-12-04	RNACCartesian Therapeutics, Inc.P Purchase	Director	PPurchase	+30K sh	$6.86	+$206K	54,366
2025-08-11	HTFLHeartflow, Inc. · Convertible Promissory NoteC Conversion	Director	CConversion	−132K sh	—	—	0
2025-08-11	HTFLHeartflow, Inc.C Conversion	Director	CConversion	+132K sh	—	—	168,357
2025-08-07	HTFLHeartflow, Inc. · Stock OptionA Award	Director	AAward	+23.7K sh	—	—	23,710
2025-01-02	RNACCartesian Therapeutics, Inc.A Award	Director	AAward	+2,600 sh	—	—	24,366
2025-01-02	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,800 sh	—	—	7,800
2024-08-12	RNACCartesian Therapeutics, Inc.P Purchase	Director	PPurchase	+7,500 sh	$12.70	+$95.3K	21,766
2024-01-02	RNACCartesian Therapeutics, Inc.A Award	Director	AAward	+178K sh	—	—	428,013
2024-01-02	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+228K sh	—	—	228,000
2023-11-13	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2023-11-13	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−87.5K sh	$0.93	−$81.4K	0
2023-11-13	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−40K sh	—	—	0
2023-11-13	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−40K sh	—	—	0
2023-11-13	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2023-11-13	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,410 sh	—	—	0
2023-11-13	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.3K sh	—	—	0
2023-01-02	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+87.5K sh	—	—	87,500
2022-05-09	RNACCartesian Therapeutics, Inc.P Purchase	Director	PPurchase	+50K sh	$0.77	+$38.7K	250,013
2022-01-14	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	$2.10	−$21K	0
2022-01-14	RNACCartesian Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$2.10	+$21K	200,013
2022-01-03	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2021-08-18	RNACCartesian Therapeutics, Inc.P Purchase	Director	PPurchase	+9,000 sh	$4.00	+$36K	190,013
2021-06-22	VEEVVEEVA SYSTEMS INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−251 sh	—	—	0
2021-06-22	VEEVVEEVA SYSTEMS INCM Exercise/Conversion	Director	MExercise/Conversion	+251 sh	—	—	6,643
2021-03-30	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2021-03-26	RNACCartesian Therapeutics, Inc.P Purchase	Director	PPurchase	+10K sh	$4.10	+$41K	181,013
2021-03-25	VEEVVEEVA SYSTEMS INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−250 sh	—	—	251
2021-03-25	VEEVVEEVA SYSTEMS INCM Exercise/Conversion	Director	MExercise/Conversion	+250 sh	—	—	6,392
2020-12-25	VEEVVEEVA SYSTEMS INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−251 sh	—	—	501
2020-12-25	VEEVVEEVA SYSTEMS INCM Exercise/Conversion	Director	MExercise/Conversion	+251 sh	—	—	6,142
2020-10-13	VEEVVEEVA SYSTEMS INCS Sale	Director	SSale	−1,292 sh	$308.69	−$399K	5,891
2020-10-08	VEEVVEEVA SYSTEMS INCS Sale	Director	SSale	−952 sh	$288.00	−$274K	7,183
2020-10-06	RNACCartesian Therapeutics, Inc.P Purchase	Director	PPurchase	+50K sh	$1.68	+$84K	171,013
2020-09-25	VEEVVEEVA SYSTEMS INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−251 sh	—	—	752
2020-09-25	VEEVVEEVA SYSTEMS INCM Exercise/Conversion	Director	MExercise/Conversion	+251 sh	—	—	8,135
2020-06-25	VEEVVEEVA SYSTEMS INC · Restricted Stock UnitsA Award	Director	AAward	+1,003 sh	—	—	1,003
2020-06-24	RNACCartesian Therapeutics, Inc. · Common WarrantsM Exercise/Conversion	Director	MExercise/Conversion	−32.8K sh	$0.13	−$4,105	0
2020-06-24	RNACCartesian Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+32.8K sh	$1.46	+$47.9K	121,013
2020-06-23	VEEVVEEVA SYSTEMS INCS Sale	Director	SSale	−347 sh	$242.00	−$84K	7,884

Recent filings

Accepted (ET)
Jul 244
BARABE TIMOTHY C0001464521-26-000109
SEC(opens sec.gov)
Jul 204
BARABE TIMOTHY C0001464521-26-000105
SEC(opens sec.gov)
Jun 184
BARABE TIMOTHY C0001464521-26-000093
SEC(opens sec.gov)
Mar 124
BARABE TIMOTHY C0001464521-26-000028
SEC(opens sec.gov)
Feb 194
BARABE TIMOTHY C0001464521-26-000022
SEC(opens sec.gov)
Jan 64
BARABE TIMOTHY C0001453687-26-000032
SEC(opens sec.gov)
Dec 84
BARABE TIMOTHY C0001453687-25-000132
SEC(opens sec.gov)
Aug 114
BARABE TIMOTHY C0001628280-25-039731
SEC(opens sec.gov)
Jan 64
BARABE TIMOTHY C0001453687-25-000021
SEC(opens sec.gov)
Aug 144
BARABE TIMOTHY C0001453687-24-000104
SEC(opens sec.gov)
Jan 44
BARABE TIMOTHY C0001453687-24-000023
SEC(opens sec.gov)

Companies

Address

C/O HEARTFLOW, INC. 135 MAIN STREET, SUITE 1000

SAN FRANCISCO, CA, 94105